Novolin Ge 30/70 Penfill 30 Unit

NOVOLIN GE 30/70 Penfill is a human biosynthetic insulin suspension designed for subcutaneous use. This 30-unit strength insulin is formulated to manage blood glucose levels in diabetic patients. Ideal for those requiring a balanced insulin regimen, it combines rapid and intermediate-acting insulin for effective control.

NOVOLIN GE 30/70 Penfill is primarily used for the management of diabetes mellitus. It helps regulate blood sugar levels by providing both immediate and prolonged insulin effects. This makes it suitable for individuals who need consistent insulin coverage throughout the day. The suspension is administered subcutaneously, making it a convenient option for daily diabetes management.

Common effects of NOVOLIN GE 30/70 Penfill may include localized reactions at the injection site, such as redness or swelling. Some users might experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. These effects vary among individuals and typically subside as the body adjusts to the medication.

NOVOLIN GE 30/70 Penfill should be handled with care to avoid contamination. It is important to store the penfill properly to maintain its efficacy. Users should be cautious about monitoring blood sugar levels regularly and adjusting their dosage as directed by a healthcare professional. Always follow the manufacturer's guidelines for safe usage.

NOVOLIN GE 30/70 Penfill may interact with certain medications, including oral hypoglycemic agents and other insulin products. Alcohol consumption can also affect blood sugar levels and should be monitored closely. It is advisable to consult a healthcare provider before combining NOVOLIN GE 30/70 Penfill with other medications to avoid potential adverse effects.